BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Amlexanox

amlexanox [Supplementary Concept] SRA-A antagonist;structure given in first source

96+ PubMed studies analyzed · 10 RCTs · Evidence Score: 47.1

Research Domains

Amlexanox has been studied across 22 research domains including 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, 🦴 Bone & Joint, 💊 Pain. The primary research focus is 🔬 Inflammation with 21% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Amlexanox, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Leflunomide
20 shared targets
2-Acetylaminofluorene
14 shared targets
Gestrinone
14 shared targets
Carboxin
11 shared targets
Lynestrenol
14 shared targets
Carbaryl
13 shared targets
Phenelzine
14 shared targets
Melphalan
16 shared targets
Betamethasone
12 shared targets
Pueraria
16 shared targets
Loading evidence profile...

This evidence profile for Amlexanox is generated deterministically from 96 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.